Ph.D. Lawrence M. Blatt

Insider Reports History

Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Lawrence M. Blatt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ph.D. Lawrence M. Blatt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aligos Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 179,800 16 Jul 2025 Direct

Insider Reports Filed by Ph.D. Lawrence M. Blatt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALGS Aligos Therapeutics, Inc. 16 Jul 2025 1 $0 4 President and CEO, Director 18 Jul 2025, 17:14
ALGS Aligos Therapeutics, Inc. 28 Feb 2025 1 $0 4 President and CEO, Director 04 Mar 2025, 16:33
ALGS Aligos Therapeutics, Inc. 04 Sep 2024 1 $0 4 Chief Executive Officer, Director 06 Sep 2024, 16:23
ALGS Aligos Therapeutics, Inc. 01 Mar 2024 1 $0 4 Chief Executive Officer, Director 04 Mar 2024, 17:41
ALGS Aligos Therapeutics, Inc. 27 Feb 2024 6 $0 4 Chief Executive Officer, Director 28 Feb 2024, 17:32
ALGS Aligos Therapeutics, Inc. 25 Oct 2023 2 +$500,000 4 Chief Executive Officer, Director 27 Oct 2023, 16:14
ALGS Aligos Therapeutics, Inc. 08 Sep 2023 1 $0 4 Chief Executive Officer 12 Sep 2023, 16:05
ALGS Aligos Therapeutics, Inc. 15 Mar 2023 1 $0 4 Chief Executive Officer 17 Mar 2023, 16:09
ALGS Aligos Therapeutics, Inc. 07 Jul 2022 1 $0 4 Chief Executive Officer 11 Jul 2022, 16:13
ALGS Aligos Therapeutics, Inc. 04 Feb 2022 2 $0 4 Chief Executive Officer 08 Feb 2022, 15:09